|
|
Pulmonology
Clinical Services
The Section of Pulmonology provides comprehensive clinical care and consultation for children with lung disorders. Care is provided at The Children's Hospital, National Jewish Health and at outreach clinics in Colorado and Montana.
Asthma Program
Director: Gwendolyn S. Kerby, MD (Pulmonology); Associate Directors: F. Dan Atkins, MD (Allergy), Monica J. Federico, MD (Pulmonology)
The Asthma Program is a multidisciplinary service providing comprehensive care for children with asthma in both an inpatient and outpatient setting. This initiative is a novel, community-based program that brings asthma specialists to private practices and has been in place for more than a year. The Program's focus is to normalize patient activity by optimizing pharmacologic therapy through extensive patient education, evaluation of contributing factors, including allergy and environmental triggers, and close monitoring of pulmonary function. Additional goals include outreach education for all health care providers and collaboration with National Jewish Health in asthma-oriented research.
Children's Interstitial Lung Disease Program
Program Director: Robin R. Deterding, MD
This clinical and research program focuses on children with complex lung disease, including all types of interstitial lung diseases such as surfactant dysfunction mutations and unique forms of interstitial lung disease (ILD) in young children and teenagers. Respiratory compromise following bone marrow transplantation and connective tissues disease is also of interest. A longitudinal study looking at biomarkers and outcome markers in these conditions is underway. Significant expertise in CT scans, pulmonary function testing (including infants), and international expertise in video-assisted and bronchoscopic lung biopsy in infants and small children creates a unique opportunity for full diagnostic and second opinion evaluations. Specialists in pediatrics, surgery, nursing, social work, and respiratory therapy provide expertise with noninvasive ventilation, immunosuppression and special diagnostic techniques, such as lung biopsy in infants and small children. Second opinion consultations are arranged for patients from around the world. Dr. Deterding is an original member for the Board of Directors of the Children's Interstitial Lung Disease Foundation (ChILD) and is the Chair of the Scientific Board for ChILD.
The Children’s Hospital Sleep Center
Director: Norman Friedman, MD (Otolaryngology); Associate Director: Keith L. Cavanaugh, MD (Pulmonology); Director of Pediatric Sleep Research: Ann C. Halbower, MD (Pulmonology); Nurse Practitioner: Carole E. Kline, MSN, CPNP.
The Children’s Hospital Sleep Center is a multidisciplinary program jointly administered by Pulmonology and Otolaryngology. A wide variety of pediatric sleep disorders is managed, including, but not limited to, central and obstructive apnea, sleep-disordered breathing, hypoventilation, narcolepsy, insomnia, and sleep phase disorders. The program includes physicians, nurses, and respiratory therapists with special experience in noninvasive ventilation of children. Patients are studied in a state-of-the-art sleep diagnostic laboratory and can be followed in several clinics that focus on family-based care.
Cystic Fibrosis Center
Director: Frank J. Accurso, MD; Associate Directors: Jerry Nick, MD (Adult Center), and Scott D. Sagel, MD (Pediatric Center)
The Cystic Fibrosis Center is a large, nationally recognized clinical and research service providing care throughout the Rocky Mountain Region. Clinical care is provided by an extensive multidisciplinary team located at The Children's Hospital (Pediatric Program), National Jewish Health (Adult Program), University of Colorado Hospital and at several outreach locations in Colorado and Montana (both adult and pediatric). As one of the Therapeutics Development Centers organized by the national Cystic Fibrosis Foundation, the Colorado CF center is active in many aspects of clinical and basic research. Special clinical and research emphasis is placed on early detection and disease pathophysiology, since Colorado was the first state in the U.S. to develop newborn screening for cystic fibrosis.
Pediatric Heart Lung Center
Director: Steven H. Abman, MD
The Pediatric Heart Lung Center (PHLC) is a unique multidisciplinary program that provides novel diagnostic and treatment strategies to children with diverse heart and lung disease, especially related to pulmonary hypertension. Members of the PHLC are actively involved in laboratory and clinical research, as well as in providing consultations to children with pulmonary hypertension as inpatients and outpatients. Clinical care is provided by a multidisciplinary group of pulmonary, cardiology and neonatology specialist physicians, nurses and respiratory therapists. Research extends from bench to bedside and focuses on pulmonary hypertension, premature babies, bronchopulmonary dysplasia, acute lung injury, and many other diseases.
Pulmonary Diagnostic Center
Director: Gwendolyn S. Kerby, MD
Diagnostic modalities include pulmonary function testing in older children, preschoolers, and infants, bronchoprovocation, and exercise testing, flexible bronchoscopy, and laryngoscopy, bronchoalveolar lavage, and transbronchial biopsy, induced sputum collection, and four-channel sleep studies.
|
|
